Breaking News
Sort by:
Top Post
Dexcom ONE on NHS Prescription Following NICE Diabetes Guidelines
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced […]
NHS Runs World-first Test into ‘Sci-Fi Like’ Artificial Pancreases
Almost 1,000 adults and children with type 1 diabetes have been given a potentially life-altering […]
Aristea Therapeutics Announces Dosing of First Patient in Phase 2b Trial of RIST4721 in Palmoplantar Pustulosis
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
Diamyd Medical Secures Precision Medicine Patent for Prevention and Treatment of Autoimmune Diabetes
The European Patent Office has informed Diamyd Medical that the Company’s patent application regarding prevention […]
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and […]
HIV Vaccine Trial HIV-CORE 0052 Starts at Oxford
The goal of the trial, known as HIV-CORE 0052, is to evaluate the safety, tolerability, […]
Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
Sosei Group Corporation (“the Company”) (TSE: 4565), the world leader in GPCR-focused structure-based drug design and […]
Atara Biotherapeutics Joins the Rare Disease Company Coalition Alongside Industry Gamechangers
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell […]
Carthera’s Sonocloud Technology Enhances the Efficacy of Immunotherapies for the Treatment of Brain Tumors
CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain […]
Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US
Prosit Sole Biotechnology, a clinical-stage biotech company developing novel protein therapeutics, today announces that it […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more